Loading…

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma

Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and molecular hepatology 2023-04, Vol.29 (2), p.453
Main Authors: Yi-te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Format: Article
Language:Korean
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 2
container_start_page 453
container_title Clinical and molecular hepatology
container_volume 29
creator Yi-te Lee
Mohammad A. Karim
Hye Chung Kum
Sulki Park
Nicole E. Rich
Mazen Noureddin
Amit G. Singal
Ju Dong Yang
description Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse of HCC surveillance in clinical practice. We characterized the frequency and associated factors of unrecognized cirrhosis in a national sample of patients with HCC from the United States. Methods: HCC patients aged 68 years and older, diagnosed during 2011 to 2015 were included from the SEER-Medicare Linked Database. If cirrhosis was diagnosed within 6 months immediately preceding HCC diagnosis or after HCC diagnosis, cases were categorized as unrecognized cirrhosis. Factors associated with unrecognized cirrhosis were identified using logistic regression analyses. Factors associated with overall survival were evaluated using Cox regression analyses. Results: Among 5,098 HCC patients, 74.8% patients had cirrhosis. Among those with cirrhosis, 57.4% had unrecognized cirrhosis, with the highest proportion (76.3%) among those with NAFLD-related HCC. Male sex (aOR: 2.12, 95% CI: 1.83-2.46), non-Hispanic Black race (aOR: 1.93, 95% CI: 1.45-2.57), and NAFLD etiology (aOR: 4.46, 95% CI: 3.68-5.41) were associated with having unrecognized cirrhosis. Among NAFLD-related HCC patients, male sex (aOR: 2.32, 95% CI: 1.71-3.14) was associated with unrecognized cirrhosis. Unrecognized cirrhosis was independently associated with worse overall survival (aHR: 1.17, 95% CI: 1.08-1.27) compared to recognized cirrhosis. Conclusions: Unrecognized cirrhosis is common in NAFLD-related HCC, particularly among male and Black patients, highlighting these groups as important intervention targets to improve HCC surveillance uptake and outcomes. (Clin Mol Hepatol 2023;29:453-464)
format article
fullrecord <record><control><sourceid>kiss</sourceid><recordid>TN_cdi_kiss_primary_4013639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><kiss_id>4013639</kiss_id><sourcerecordid>4013639</sourcerecordid><originalsourceid>FETCH-kiss_primary_40136393</originalsourceid><addsrcrecordid>eNp9ikEOgjAQRbvQRKKcwE0vQAK0Cq6NxAO4cEfGWmViaclMidHTS6JrVz_vvT8TSVnWVVZWZb0QKTNecq0rpQq9ScS5ARMDsQTmYBCivconxk6OnqwJd4_vyRgk6gIjS_RygIjWR_7-OjtxMNa50QFJA2TQhx5WYn4Dxzb97VKsm8Npf8weyNwOhD3Qq9V5obZqp_7XD1QIPeo</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Yi-te Lee ; Mohammad A. Karim ; Hye Chung Kum ; Sulki Park ; Nicole E. Rich ; Mazen Noureddin ; Amit G. Singal ; Ju Dong Yang</creator><creatorcontrib>Yi-te Lee ; Mohammad A. Karim ; Hye Chung Kum ; Sulki Park ; Nicole E. Rich ; Mazen Noureddin ; Amit G. Singal ; Ju Dong Yang</creatorcontrib><description>Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse of HCC surveillance in clinical practice. We characterized the frequency and associated factors of unrecognized cirrhosis in a national sample of patients with HCC from the United States. Methods: HCC patients aged 68 years and older, diagnosed during 2011 to 2015 were included from the SEER-Medicare Linked Database. If cirrhosis was diagnosed within 6 months immediately preceding HCC diagnosis or after HCC diagnosis, cases were categorized as unrecognized cirrhosis. Factors associated with unrecognized cirrhosis were identified using logistic regression analyses. Factors associated with overall survival were evaluated using Cox regression analyses. Results: Among 5,098 HCC patients, 74.8% patients had cirrhosis. Among those with cirrhosis, 57.4% had unrecognized cirrhosis, with the highest proportion (76.3%) among those with NAFLD-related HCC. Male sex (aOR: 2.12, 95% CI: 1.83-2.46), non-Hispanic Black race (aOR: 1.93, 95% CI: 1.45-2.57), and NAFLD etiology (aOR: 4.46, 95% CI: 3.68-5.41) were associated with having unrecognized cirrhosis. Among NAFLD-related HCC patients, male sex (aOR: 2.32, 95% CI: 1.71-3.14) was associated with unrecognized cirrhosis. Unrecognized cirrhosis was independently associated with worse overall survival (aHR: 1.17, 95% CI: 1.08-1.27) compared to recognized cirrhosis. Conclusions: Unrecognized cirrhosis is common in NAFLD-related HCC, particularly among male and Black patients, highlighting these groups as important intervention targets to improve HCC surveillance uptake and outcomes. (Clin Mol Hepatol 2023;29:453-464)</description><identifier>ISSN: 2287-2728</identifier><language>kor</language><publisher>대한간학회</publisher><subject>Cancer screening ; Hepatocellular carcinoma ; Liver cirrhosis ; NAFLD</subject><ispartof>Clinical and molecular hepatology, 2023-04, Vol.29 (2), p.453</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Yi-te Lee</creatorcontrib><creatorcontrib>Mohammad A. Karim</creatorcontrib><creatorcontrib>Hye Chung Kum</creatorcontrib><creatorcontrib>Sulki Park</creatorcontrib><creatorcontrib>Nicole E. Rich</creatorcontrib><creatorcontrib>Mazen Noureddin</creatorcontrib><creatorcontrib>Amit G. Singal</creatorcontrib><creatorcontrib>Ju Dong Yang</creatorcontrib><title>Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma</title><title>Clinical and molecular hepatology</title><addtitle>Clinical and Molecular Hepatology(대한간학회지)</addtitle><description>Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse of HCC surveillance in clinical practice. We characterized the frequency and associated factors of unrecognized cirrhosis in a national sample of patients with HCC from the United States. Methods: HCC patients aged 68 years and older, diagnosed during 2011 to 2015 were included from the SEER-Medicare Linked Database. If cirrhosis was diagnosed within 6 months immediately preceding HCC diagnosis or after HCC diagnosis, cases were categorized as unrecognized cirrhosis. Factors associated with unrecognized cirrhosis were identified using logistic regression analyses. Factors associated with overall survival were evaluated using Cox regression analyses. Results: Among 5,098 HCC patients, 74.8% patients had cirrhosis. Among those with cirrhosis, 57.4% had unrecognized cirrhosis, with the highest proportion (76.3%) among those with NAFLD-related HCC. Male sex (aOR: 2.12, 95% CI: 1.83-2.46), non-Hispanic Black race (aOR: 1.93, 95% CI: 1.45-2.57), and NAFLD etiology (aOR: 4.46, 95% CI: 3.68-5.41) were associated with having unrecognized cirrhosis. Among NAFLD-related HCC patients, male sex (aOR: 2.32, 95% CI: 1.71-3.14) was associated with unrecognized cirrhosis. Unrecognized cirrhosis was independently associated with worse overall survival (aHR: 1.17, 95% CI: 1.08-1.27) compared to recognized cirrhosis. Conclusions: Unrecognized cirrhosis is common in NAFLD-related HCC, particularly among male and Black patients, highlighting these groups as important intervention targets to improve HCC surveillance uptake and outcomes. (Clin Mol Hepatol 2023;29:453-464)</description><subject>Cancer screening</subject><subject>Hepatocellular carcinoma</subject><subject>Liver cirrhosis</subject><subject>NAFLD</subject><issn>2287-2728</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9ikEOgjAQRbvQRKKcwE0vQAK0Cq6NxAO4cEfGWmViaclMidHTS6JrVz_vvT8TSVnWVVZWZb0QKTNecq0rpQq9ScS5ARMDsQTmYBCivconxk6OnqwJd4_vyRgk6gIjS_RygIjWR_7-OjtxMNa50QFJA2TQhx5WYn4Dxzb97VKsm8Npf8weyNwOhD3Qq9V5obZqp_7XD1QIPeo</recordid><startdate>20230401</startdate><enddate>20230401</enddate><creator>Yi-te Lee</creator><creator>Mohammad A. Karim</creator><creator>Hye Chung Kum</creator><creator>Sulki Park</creator><creator>Nicole E. Rich</creator><creator>Mazen Noureddin</creator><creator>Amit G. Singal</creator><creator>Ju Dong Yang</creator><general>대한간학회</general><scope>HZB</scope><scope>Q5X</scope></search><sort><creationdate>20230401</creationdate><title>Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma</title><author>Yi-te Lee ; Mohammad A. Karim ; Hye Chung Kum ; Sulki Park ; Nicole E. Rich ; Mazen Noureddin ; Amit G. Singal ; Ju Dong Yang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-kiss_primary_40136393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>kor</language><creationdate>2023</creationdate><topic>Cancer screening</topic><topic>Hepatocellular carcinoma</topic><topic>Liver cirrhosis</topic><topic>NAFLD</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yi-te Lee</creatorcontrib><creatorcontrib>Mohammad A. Karim</creatorcontrib><creatorcontrib>Hye Chung Kum</creatorcontrib><creatorcontrib>Sulki Park</creatorcontrib><creatorcontrib>Nicole E. Rich</creatorcontrib><creatorcontrib>Mazen Noureddin</creatorcontrib><creatorcontrib>Amit G. Singal</creatorcontrib><creatorcontrib>Ju Dong Yang</creatorcontrib><collection>Korean Studies Information Service System (KISS)</collection><collection>Korean Studies Information Service System (KISS) B-Type</collection><jtitle>Clinical and molecular hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yi-te Lee</au><au>Mohammad A. Karim</au><au>Hye Chung Kum</au><au>Sulki Park</au><au>Nicole E. Rich</au><au>Mazen Noureddin</au><au>Amit G. Singal</au><au>Ju Dong Yang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma</atitle><jtitle>Clinical and molecular hepatology</jtitle><addtitle>Clinical and Molecular Hepatology(대한간학회지)</addtitle><date>2023-04-01</date><risdate>2023</risdate><volume>29</volume><issue>2</issue><spage>453</spage><pages>453-</pages><issn>2287-2728</issn><abstract>Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is often asymptomatic and can go undiagnosed for years, leading to underuse of HCC surveillance in clinical practice. We characterized the frequency and associated factors of unrecognized cirrhosis in a national sample of patients with HCC from the United States. Methods: HCC patients aged 68 years and older, diagnosed during 2011 to 2015 were included from the SEER-Medicare Linked Database. If cirrhosis was diagnosed within 6 months immediately preceding HCC diagnosis or after HCC diagnosis, cases were categorized as unrecognized cirrhosis. Factors associated with unrecognized cirrhosis were identified using logistic regression analyses. Factors associated with overall survival were evaluated using Cox regression analyses. Results: Among 5,098 HCC patients, 74.8% patients had cirrhosis. Among those with cirrhosis, 57.4% had unrecognized cirrhosis, with the highest proportion (76.3%) among those with NAFLD-related HCC. Male sex (aOR: 2.12, 95% CI: 1.83-2.46), non-Hispanic Black race (aOR: 1.93, 95% CI: 1.45-2.57), and NAFLD etiology (aOR: 4.46, 95% CI: 3.68-5.41) were associated with having unrecognized cirrhosis. Among NAFLD-related HCC patients, male sex (aOR: 2.32, 95% CI: 1.71-3.14) was associated with unrecognized cirrhosis. Unrecognized cirrhosis was independently associated with worse overall survival (aHR: 1.17, 95% CI: 1.08-1.27) compared to recognized cirrhosis. Conclusions: Unrecognized cirrhosis is common in NAFLD-related HCC, particularly among male and Black patients, highlighting these groups as important intervention targets to improve HCC surveillance uptake and outcomes. (Clin Mol Hepatol 2023;29:453-464)</abstract><pub>대한간학회</pub><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2287-2728
ispartof Clinical and molecular hepatology, 2023-04, Vol.29 (2), p.453
issn 2287-2728
language kor
recordid cdi_kiss_primary_4013639
source Open Access: PubMed Central; Publicly Available Content (ProQuest)
subjects Cancer screening
Hepatocellular carcinoma
Liver cirrhosis
NAFLD
title Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A03%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-kiss&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20associated%20with%20unrecognized%20cirrhosis%20in%20patients%20with%20hepatocellular%20carcinoma&rft.jtitle=Clinical%20and%20molecular%20hepatology&rft.au=Yi-te%20Lee&rft.date=2023-04-01&rft.volume=29&rft.issue=2&rft.spage=453&rft.pages=453-&rft.issn=2287-2728&rft_id=info:doi/&rft_dat=%3Ckiss%3E4013639%3C/kiss%3E%3Cgrp_id%3Ecdi_FETCH-kiss_primary_40136393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_kiss_id=4013639&rfr_iscdi=true